Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
Syros Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
Syros Pharmaceuticals reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, three executives at Syros Pharmaceuticals received on average a compensation package of $1.6M, a 28% decrease compared to previous year.
Average pay of disclosed executives at Syros Pharmaceuticals
Nancy Simonian, Chief Executive Officer, received $2.5M in total, which decreased by 30% compared to 2019. 59% of Simonian's compensation, or $1.5M, was in option awards. Simonian also received $429K in non-equity incentive plan, $598K in salary, as well as $360 in other compensation.
David A. Roth, Chief Medical Officer, received a compensation package of $1.2M, which decreased by 26% compared to previous year. 40% of the compensation package, or $481K, was in option awards.
Eric R. Olson, Chief Scientific Officer, earned $1.2M in 2020, a 27% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2021.